Goldman: state pauses may stall 45% of planned US data centre capacity, briefly
Goldman says states set to tighten data centre rules account for 45% of planned US capacity, but expects any pauses to be short-lived.
China's central bank and regulators plan to meet Monday to discuss stock market support tools, after the CSI 300 fell 8.5% in October.
Equities in mainland China and Hong Kong get their first chance on Monday to respond to the reports, and expectations of government support could lift opening sentiment following October's steep declines. How long that holds will probably come down to specifics. Market participants have watched last month's measures do little to stop the drop, meaning the size and conditions of any expanded relending facility carry more weight than the announcement itself. A believable rescue package might also take some heat off the yuan and regional risk appetite. If no firm measures emerge, shrinking PMI readings and uncertainty over AI profits keep the bearish scenario intact.
Following a historic slide in Chinese equities, Beijing seems to be pulling together additional support levers, even though the previous month demonstrated that a mere hint of action won't suffice.
Key points:
The People's Bank of China is scheduled to sit down with the nation's financial regulators and top banks on Monday to talk over measures to bolster the stock market, Chinese media report, as officials come under growing pressure to check a sharp fall in share prices.
According to financial publication Cailian, which cited industry sources on Sunday, the central bank will sit down with the National Financial Regulatory Administration, the China Securities Regulatory Commission and major lenders to examine possible improvements to a relending facility for buybacks and stake increases. The programme allows companies and major shareholders to take out bank loans, with central bank funding backing the arrangement, to buy back their own shares.
The 21st Century Business Herald said some securities companies and fund houses had already been told about the gathering. According to the paper, industry observers suspect the meeting may be groundwork by regulators for additional steps to steady the market. Neither the meeting's agenda nor any specific policies have been officially confirmed.
Fresh state support would build on the measures rolled out last month to calm the stock market. Those actions have yet to shift investor sentiment, with a soft home economy and scepticism about AI profits continuing to hang over the market. The CSI 300, which tracks leading Shanghai and Shenzhen equities, lost 8.5% in October and moved into bear-market territory. That marked a record 12th consecutive weekly fall and the biggest monthly drop for Chinese stocks in over a decade.
The slide has come alongside fresh indications of economic weakness. Official PMI data published on Saturday showed both manufacturing and non-manufacturing activity moving back into contraction during October, with the factory gauge at 49.3 and the non-manufacturing index at 49.7.
Monday's talks will be closely scrutinised for clues about the size and pace of any fresh measures. A substantial enlargement of the relending scheme would indicate that Beijing is ready to devote greater firepower to the market. If the meeting delivers only minor adjustments, it risks echoing last month's outcome, when policy moves failed to turn the slide around.
Share to
Disclaimer: this article comes from third-party media and is provided for reference only. It does not constitute investment advice. Crypto and other financial products carry significant price volatility risk, so please make your own decisions carefully.
Goldman says states set to tighten data centre rules account for 45% of planned US capacity, but expects any pauses to be short-lived.
After the Democratic midterm sweep, Fundstrat's Tom Lee expects tech stocks to climb 15%-20% as hedge funds rebuild exposure; data center stocks fell Wednesday.
AstraZeneca reportedly made a $10 billion offer for Rhythm Pharmaceuticals, sending shares up 28% and targeting the obesity and rare disease markets.
The S&P 500 hit an extreme oversold level on Nov. 2 even as 46.8% of its stocks were overbought, a split unseen in 36 years.